H
Helicon Therapeutics
A privately held Company formed to discover therapeutics to treat disorders of cognition through an understanding of the genetic basis of long-term memory formation
About Helicon Therapeutics
Helicon Therapeutics was a privately held biopharmaceutical company that focused on the discovery and development of novel drugs for the treatment of cognitive disorders. The company's research was centered on understanding the genetic and molecular basis of memory formation, with the goal of identifying new therapeutic targets for conditions such as Alzheimer's disease, age-related memory loss, and other neurological disorders.
Helicon's business model was based on a research-intensive approach, leveraging its expertise in neuroscience and genetics to build a pipeline of potential drug candidates. The company was founded in 1997 as a spin-off from Cold Spring Harbor Laboratory, a renowned research institution. This academic affiliation provided Helicon with a strong scientific foundation and access to cutting-edge research.
The company operated in the highly competitive and regulated pharmaceutical industry, where the development of new drugs is a lengthy and expensive process. Helicon's strategy likely involved seeking partnerships with larger pharmaceutical companies to advance its drug candidates through clinical trials and commercialization. The company was ultimately acquired, which is a common exit strategy for successful biotechnology startups.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES FOther financing | Sep 2009 | $50M | $200M | Undisclosed | — |
| SERIES EOther financing | Oct 2006 | $36M | $144M | Undisclosed | — |
Growth signals
Latest recorded traffic for Helicon Therapeutics is 0 monthly website visits. Helicon Therapeutics's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Helicon Therapeutics in the Town of Huntington ecosystem
The Helicon Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors1 additional known investor
Cold Spring Harbor Laboratory
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Helicon Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Helicon Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








